Last reviewed · How we verify

NCT05289414

Pulsed Radiofrquency Targeting Mid Cervical Medial Branches Versus GON for Cervicogenic Headache

Completed NA Last updated 7 March 2025
What this trial tests

NA trial testing Radiofrequency on mid cervical medial branches in Cervicogenic Headache in 43 participants. Completed in 31 December 2024.

Timeline
1 September 2022
Primary endpoint
1 November 2024
31 December 2024

Quick facts

Lead sponsorAssiut University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposesupportive care
Enrollment43
Start date1 September 2022
Primary completion1 November 2024
Estimated completion31 December 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 18 to 85, any sex, with Cervicogenic Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To detect the Clinical efficacy of pulsed radiofrequency treatment targeting the mid cervical medial branches versus greater occipital nerve for cervicogenic headache

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cervicogenic Headache

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05289414.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing